About us
The Vaccine and Gene Therapy Institute at Oregon Health & Science University has assembled a multidisciplinary team of scientists to respond to serious viral disease threats, including AIDS, chronic viral infection-associated diseases, newly emerging viral diseases and infectious diseases of the elderly. Our programs are intended to span the continuum between basic and clinical science, in which discoveries are rapidly advanced from the level of molecular and cellular biology through animal models and ultimately into clinical testing. Learn more
Upcoming seminars
VGTI Seminar Series and Virology Journal Club is now streamed online. Please reach out to Chad (sixkille@ohsu.edu) if you would like a link to the live stream.

Recent publications
J Med Chem. April 9, 2021
Targeting Chikungunya Virus Replication by Benzoannulene Inhibitors
PLoS Negl Trop Dis. April 1, 2021
Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses
mBio. March 30, 2021
Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus
Sci Immunol. March 25, 2021
Cytomegaloviral determinants of CD8+ T cell programming and RhCMV/SIV vaccine efficacy
Science. March 25, 2021
Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy
Sci Immunol. March 25, 2021
HLA-E-restricted, Gag-specific CD8 + T cells can suppress HIV-1 infection, offering vaccine opportunities
Eur J Nucl Med Mol Imaging. March 18, 2021
Applicability, potential and limitations of TSPO PET imaging as a clinical immunopsychiatry biomarker
Cell Host Microbe. March 5, 2021
TGFβ restricts expansion, survival, and function of T cells within the tuberculous granuloma
Donate to VGTI
Your gifts help provide vital resources to conduct innovative research and more.


COVID-19 Efforts - Building a COVID Testing Lab